Technical Analysis for GOVX - GeoVax Labs, Inc.

Grade Last Price % Change Price Change
grade C 3.01 -0.99% -0.03
GOVX closed down 0.99 percent on Friday, October 23, 2020, on 48 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Very Strong N/A Up Down
Historical GOVX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -0.99%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.99%
Wide Bands Range Expansion -0.99%
Older End-of-Day Gignals for GOVX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; U.S. Army Research Institute of Infectious Disease; U.S. Naval Research Laboratory; Emory University; University of Pittsburgh; Georgia State University Research Foundation; University of Texas Medical Branch; the Institute of Human Virology at the University of Maryland; the Scripps Research Institute; the Burnet Institute; American Gene Technologies, Inc.; Viamune, Inc.; Vaxeal Holding SA; CaroGen Corporation; Virometix AG; U.S. Department of Defense; Geneva Foundation; Enesi Pharma; and Leidos, Inc. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.

Is GOVX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 3.8
52 Week Low 0.1152
Average Volume 308,955
200-Day Moving Average 0.00
50-Day Moving Average 1.43
20-Day Moving Average 2.94
10-Day Moving Average 3.12
Average True Range 0.32
ADX 58.68
+DI 37.59
-DI 9.63
Chandelier Exit (Long, 3 ATRs ) 2.84
Chandelier Exit (Short, 3 ATRs ) 1.21
Upper Bollinger Band 4.23
Lower Bollinger Band 1.65
Percent B (%b) 0.53
BandWidth 87.72
MACD Line 0.53
MACD Signal Line 0.60
MACD Histogram -0.0749
Fundamentals Value
Market Cap 41.6 Million
Num Shares 13.8 Million
EPS -5.62
Price-to-Earnings (P/E) Ratio -0.54
Price-to-Sales 4.33
Price-to-Book 0.00
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.24
Resistance 3 (R3) 3.24 3.16 3.20
Resistance 2 (R2) 3.16 3.11 3.16 3.18
Resistance 1 (R1) 3.09 3.07 3.05 3.09 3.17
Pivot Point 3.01 3.01 3.00 3.01 3.01
Support 1 (S1) 2.94 2.96 2.90 2.94 2.85
Support 2 (S2) 2.86 2.92 2.86 2.84
Support 3 (S3) 2.79 2.86 2.82
Support 4 (S4) 2.79